13F
← All fund report cards

PALISADE CAPITAL MANAGEMENT, LP

13F equity value
$3.0B
Positions
303
Top 10 concentration
17.0%
Quarters / total new picks
32 / 347
13F equity value over time
$0M$2B$5B2017201820192020202120222023202420252026

"13F equity value" = market value of this filer's US-listed long equity positions only. It excludes cash, bonds, non-US and short positions, so it understates a fund's true assets under management — often by a lot.

Not significant Verdict

13F holdings are disclosed ~45 days after quarter-end, and they never reveal when within the quarter a fund actually bought. So any 13F-based summary is structurally late and blurred — this applies to every fund, including this one.

We backtested copying it anyway. Buying this fund's new positions the day each filing went public, over 32 quarters, returned +1.0% per quarter — versus +2.7% per quarter from simply owning every 13F stock. It beat that baseline in only 56.2% of quarters (excess t = 0.14, not statistically significant). Its filings tell you what it bought — not what you should buy.

Avg 2Q excess
+0.4%
t-stat
0.14
Quarterly win rate
56%
Annualized excess
-11.0%
$1 → follow vs universe
$0.90 vs $2.09
Cumulative return: $1 invested in new picks vs universe
1.00 20180331: universe 1.04120180630: universe 0.95920180930: universe 1.00320181231: universe 0.99220190331: universe 0.97520190630: universe 1.04820190930: universe 1.12720191231: universe 0.90920200331: universe 1.09620200630: universe 1.21120200930: universe 1.48520201231: universe 1.55320210331: universe 1.56620210630: universe 1.69220210930: universe 1.51920211231: universe 1.29220220331: universe 1.38720220630: universe 1.28520220930: universe 1.38120221231: universe 1.28220230331: universe 1.35120230630: universe 1.30320230930: universe 1.47920231231: universe 1.54520240331: universe 1.58020240630: universe 1.72320240930: universe 1.70820241231: universe 1.59420250331: universe 1.73820250630: universe 1.79320250930: universe 2.01620251231: universe 2.085 20180331: follow 1.04620180630: follow 0.97220180930: follow 1.02120181231: follow 0.93820190331: follow 0.94620190630: follow 1.05020190930: follow 1.10620191231: follow 1.01220200331: follow 1.17820200630: follow 1.18720200930: follow 1.47520201231: follow 1.41920210331: follow 1.62020210630: follow 1.77920210930: follow 0.76420211231: follow 0.66320220331: follow 0.68420220630: follow 0.60020220930: follow 0.54420221231: follow 0.54920230331: follow 0.52920230630: follow 0.53820230930: follow 0.58220231231: follow 0.61020240331: follow 0.52120240630: follow 0.65120240930: follow 0.71620241231: follow 0.68420250331: follow 0.83920250630: follow 0.83920250930: follow 0.81920251231: follow 0.895 0.48 1.37 2.25 20182019202020212022202320242025 Follow Universe

Quarterly compounding, invested quarters only · entry 47 days after quarter-end (when 13F data becomes public)

Listed as facts. See the verdict above before treating this as signal.

Top 20 holdings of 303 · 2026 Q1

Ticker Value Weight QoQ
AAPL $62M
2.1%
ADD
LFUS $58M
1.9%
ADD
APH $56M
1.9%
TRIM
IDA $54M
1.8%
TRIM
IGSB $53M
1.8%
ADD
AIT $49M
1.6%
TRIM
MLI $49M
1.6%
TRIM
RJF $47M
1.6%
TRIM
NVDA $44M
1.5%
TRIM
GOOG $39M
1.3%
HOLD
WSFS $38M
1.3%
TRIM
HEI/A $37M
1.2%
HOLD
WWD $37M
1.2%
TRIM
SMTC $37M
1.2%
TRIM
NGVT $35M
1.2%
TRIM
JPM $35M
1.2%
HOLD
MSFT $34M
1.1%
HOLD
EGP $33M
1.1%
TRIM
ONTO $32M
1.1%
TRIM
PB $32M
1.1%
TRIM

QoQ vs previous quarter's share count · NEW = new position · ADD/TRIM = ±2% shares · HOLD = unchanged.

Listed as facts. See the verdict above before treating this as signal.

New positions in 2026 Q1

Method & Limitations

Method: a "new position" = held this quarter, absent last quarter (options excluded; stocks with <50 prior holders excluded to filter spin-off artifacts). Entry 47 days after quarter-end — the first day the public could act on the filing. Benchmark = equal-weighted universe of all 13F-held stocks. Limitations: quarterly snapshots can't see intra-quarter trades; survivorship bias — funds that shut down are absent, which flatters the sample. Statistics, not advice.